Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fine Foods & Pharmaceuticals NTM SpAMIL:FF -0.70%70 3-Year EBITDA Growth Rate is 122.20% as of Mar. 2026, which is 172% above its 10-year median of 44.90. GuruFocus rates MIL:FF with a GF Score™ of 70/100 and a GF Value™ of €9.36 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,661 Consumer Packaged Goods companies, Fine Foods & Pharmaceuticals NTM SpA ranks better than 97.71% on this metric.
During the past 12 months, Fine Foods & Pharmaceuticals NTM SpA's average EBITDA Per Share Growth Rate was 0.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 122.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 18.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fine Foods & Pharmaceuticals NTM SpA was 493.00% per year. The lowest was -39.90% per year. And the median was 44.90% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Fine Foods & Pharmaceuticals NTM SpA 3-Year EBITDA Growth Rate Related Terms
MIL:FF vs KHC, GIS: 3-Year EBITDA Growth Rate Comparison
For the Packaged Foods subindustry, Fine Foods & Pharmaceuticals NTM SpA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fine Foods & Pharmaceuticals NTM SpA 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Fine Foods & Pharmaceuticals NTM SpA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Fine Foods & Pharmaceuticals NTM SpA's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 122.20% mean?
Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) has a 3-Year EBITDA Growth Rate of 122.20% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Fine Foods & Pharmaceuticals NTM SpA and its competitors. This is 172% above median its historical median of 44.90. According to the industry distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #38 out of 1661 companies in the Consumer Packaged Goods industry, placing it in the top 2.3%.
Is Fine Foods & Pharmaceuticals NTM SpA's 3-Year EBITDA Growth Rate too high?
Fine Foods & Pharmaceuticals NTM SpA's current 3-Year EBITDA Growth Rate of 122.20% is 172% above median its 10-year median of 44.90. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 8.00. Fine Foods & Pharmaceuticals NTM SpA's value of 122.20% is 1427.5% above this industry median. Based on the distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #38 out of 1661 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Fine Foods & Pharmaceuticals NTM SpA has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fine Foods & Pharmaceuticals NTM SpA's 3-Year EBITDA Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Fine Foods & Pharmaceuticals NTM SpA ranks #38 out of 1661 companies for 3-Year EBITDA Growth Rate. This places Fine Foods & Pharmaceuticals NTM SpA in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.00. Fine Foods & Pharmaceuticals NTM SpA's value of 122.20% is 1427.5% above this benchmark. While the company's 10-year median is 44.90 vs. the industry median of 8.00, Fine Foods & Pharmaceuticals NTM SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.00, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fine Foods & Pharmaceuticals NTM SpA's current 3-Year EBITDA Growth Rate of 122.20% is 1427.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Fine Foods & Pharmaceuticals NTM SpA and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fine Foods & Pharmaceuticals NTM SpA's current 3-Year EBITDA Growth Rate is 122.20%, which is 172% above median its own 10-year median of 44.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fine Foods & Pharmaceuticals NTM SpA stock overvalued right now?
Based on GuruFocus' analysis, Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) is currently considered Fairly Valued. The stock's GF Value™ is €9.36, compared to a current price of €8.54 — trading 8.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 122.20%, which is 172% above median its 10-year median of 44.90 and 1427.5% above the Consumer Packaged Goods industry median of 8.00. Fine Foods & Pharmaceuticals NTM SpA's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Fine Foods & Pharmaceuticals NTM SpA (MIL:FF), the current 3-Year EBITDA Growth Rate is 122.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) Overvalued in 2026?
Based on GuruFocus' analysis, Fine Foods & Pharmaceuticals NTM SpA stock appears to be undervalued.
The current stock price of €8.54 is trading 8.8% below its estimated GF Value™ of €9.36.
GuruFocus considers Fine Foods & Pharmaceuticals NTM SpA to be Fairly Valued.
Key valuation signals for MIL:FF:
3-Year EBITDA Growth Rate: 122.20% (172% above median its 10-year median of 44.90)
GF Value™: €9.36 vs. price of €8.54 (8.8% below fair value)
Industry Position: 1427.5% above the Consumer Packaged Goods median (#38 of 1661)
No single metric tells the full story. See the MIL:FF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fine Foods & Pharmaceuticals NTM SpA is engaged in contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices in solid oral forms. The company produces pharmaceutical products such as powders and granules, tablets, film tablets, and hard gelatin capsules, packed in sachets, blisters, and pillows.
70GF Score
Get the complete analysis for MIL:FF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:FF has been successfully added to your 
